An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome

NCT01193348 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Atypical Hemolytic-Uremic Syndrome

Interventions

DRUG: Eculizumab

Sponsor

Alexion Pharmaceuticals, Inc.